N-acetyltransferase 2 polymorphisms and risk of esophageal cancer in a chinese population

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wang, Liming ^a   Tang, Weifeng ^a   Chen, Suocheng ^a   Sun, Yangyong ^a   Fan, Yu ^a   Shi, Yijun ^a   Zhu, Jingfeng ^a   Wang, Xu ^a   Zheng, Liang ^b   Shao, Aizhong ^a   Ding, Guowen ^a   Liu, Chao ^a   Liu, Ruiping ^c   Yin, Jun ^a   Gu, Haiyong ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; GENOMIC DNA; NAT2 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HIGH RISK POPULATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY; ASIAN CONTINENTAL ANCESTRY GROUP; ENZYMOLOGY; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

ARYLAMINE N-ACETYLTRANSFERASE; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84896789247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087783     Document Type: Article

References (20)

1. Chen W, He Y, Zheng R, Zhang S, Zeng H, et al. (2013) Esophageal cancer incidence and mortality in China, 2009. J Thorac Dis 5: 19-26.
2. Gu H, Ding G, Zhang W, Liu C, Chen Y, et al. (2012) Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep 39: 9105-9111.
3. Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9: 193-203.
4. Garcia-Martin E (2008) Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Curr Drug Metab 9: 487-497.
5. Walker K, Ginsberg G, Hattis D, Johns DO, Guyton KZ, et al. (2009) Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity. J Toxicol Environ Health B Crit Rev 12: 440-472.
6. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, et al. (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16: 39-52.
7. Manabe S, Tohyama K, Wada O, Aramaki T (1991) Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis 12: 1945-1947.
8. Wei J, Zheng L, Liu S, Yin J, Wang L, et al. (2013) MiR-196a2 rs11614913 T>C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol 74: 1199-1205.
9. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, et al. (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43: 55-59.
10. Yin J, Wang X, Zheng L, Shi Y, Wang L, et al. (2013) Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A Polymorphisms Are Associated with the Risk of Esophageal Cancer in a Chinese Population. PLoS One 8: e80570.
11. Liu L, Wagner CR, Hanna PE (2009) Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines. Chem Res Toxicol 22: 1962-1974.
12. Morita S, Yano M, Tsujinaka T, Ogawa A, Taniguchi M, et al. (1998) Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 79: 517-520. (Pubitemid 28445275)
13. Lee JM, Lee YC, Yang SY, Shi WL, Lee CJ, et al. (2000) Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 89: 458-464.
14. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, et al. (2007) Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population. Cancer Invest 25: 340-346. (Pubitemid 47185079)
15. Malik MA, Upadhyay R, Modi DR, Zargar SA, Mittal B (2009) Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley. Arch Med Res 40: 416-423.
16. Cui D, Wang Z, Zhao E, Ma J, Lu W (2011) NAT2 polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 73: 153-157.
17. Zhong X, Hui C, Xiao-Ling W, Yan L, Na L (2010) NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis. Arch Med Res 41: 275-280.
18. Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, et al. (2010) NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 123: 877-883.
19. Gong C, Hu X, Gao Y, Cao Y, Gao F, et al. (2011) A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review. Med Oncol 28: 365-376.
20. Liao G, Wang Y, Zhou YQ, Li TW, Zeng DQ, et al. (2013) Host genetic susceptibility to oral cancer: evidence from meta-analyses and pooled analyses. Oral Dis.